Search Results

Multi-Product Pipeline Toward Clinical Studies Confo Therapeutics Appoints Dieter Weinand, Former CEO Of Bayer Pharmaceuticals Wainwright 25th Annual Global Investment Conference X4 Pharmaceuticals to Participate in the Morgan Stanley

"Geneva, Switzerland, August 15, 2022 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical

Confo Therapeutics today announced that it has entered into a collaborative agreement with Regeneron Pharmaceuticals

Switzerland, December 17, 2021 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical

inactive conformation using molecular dynamic simulations "The δ-opioid receptor (DOR) is a critical pharmaceutical

Switzerland, July 22, 2022 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical

However, AlphaFold3 faces challenges with synthetic ligands, which are central to pharmaceutical development

given the Society’s conference will be held in Perth next year, in collaboration with the Australasian Pharmaceutical

2011, she had established her own group within the Drug Discovery Biology theme at Monash Institute of Pharmaceutical

In recent years, pharmaceutical companies have begun to utilize cryo-EM for structure-based drug design

But at Monash Institute of Pharmaceutical Sciences, a different idea took root: what if collaboration

not only deepens our understanding of a key biological process but also provides a valuable map for pharmaceutical

By identifying key β2AR residues that influence efficacy and potency, pharmaceutical researchers can

She entered undergrad set on becoming a pharmacist. kind of had an identity crisis because I think I realized in that moment that I didn't want to be a pharmacist

Industry News X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market Andrew

develop new therapies for people living with obesity, diabetes and other serious metabolic diseases X4 Pharmaceuticals

Nordisk looks to next generation of obesity, diabetes drugs with $550M Replicate research deal; Rhythm Pharmaceuticals

exclusively to our Premium Members this week: Industry insights:  Discover the latest strategic moves in the pharmaceutical

all symptoms of schizophrenia Sosei Heptares to receive US$2.5 million milestone payment from Formosa Pharmaceuticals

📰 GPCR Weekly News, July 22 to 28, 2024 In the fast-paced world of pharmaceuticals and drug discovery

in nearly all physiological systems make GPCR the largest protein family targeted for development of pharmaceuticals

Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating

amended deal with Gilead on anti-CCR8 antibody InterAx Biotech Announces the Appointment of Seasoned Pharmaceutical

GPCR–Gαs–PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure Industry News X4 Pharmaceuticals

Exscientia Announces Sixth Molecule Created Through Generative AI Platform to Enter Clinical Stage X4 Pharmaceuticals

Industry News Design Pharmaceuticals has a new website Confo Therapeutics Announces Global Licensing

extraordinary opportunity to generate proprietary chemo-informatics for GPCR drug discovery - Design Pharmaceuticals

Can the pharmaceutical industry reduce attrition rates? Acta Pharmaceutica Sinica B. 2022;12(7):3049-3062. 6.            Wouters OJ, McKee M, Luyten J. Innovation in the pharmaceutical industry: New estimates of R&D costs.